Human body fluid proteome analysis
|
journal
|
December 2006 |
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
|
journal
|
November 2009 |
The Human Plasma Proteome: History, Character, and Diagnostic Prospects
|
journal
|
October 2002 |
Utilizing Human Blood Plasma for Proteomic Biomarker Discovery †
|
journal
|
August 2005 |
Mining the plasma proteome for cancer biomarkers
|
journal
|
April 2008 |
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
|
journal
|
August 2006 |
Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the Future
|
journal
|
October 2007 |
Advances in Urinary Proteome Analysis and Biomarker Discovery
|
journal
|
February 2007 |
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|
journal
|
August 2010 |
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease
|
journal
|
January 2010 |
Urine as a source for clinical proteome analysis: From discovery to clinical application
|
journal
|
May 2014 |
Urine Collection and Processing for Protein Biomarker Discovery and Quantification
|
journal
|
March 2010 |
Salivary diagnostics powered by nanotechnologies, proteomics and genomics
|
journal
|
March 2006 |
Label-Free Biochemical Analytic Method for the Early Detection of Adenoviral Conjunctivitis Using Human Tear Biofluids
|
journal
|
October 2014 |
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
|
journal
|
August 2009 |
Immunoaffinity chromatography: an introduction to applications and recent developments
|
journal
|
April 2010 |
Affinity separation and enrichment methods in proteomic analysis
|
journal
|
August 2008 |
Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications
|
journal
|
October 2006 |
Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy
|
journal
|
July 2008 |
Immunoaffinity Enrichment and Liquid Chromatography-Selected Reaction Monitoring Mass Spectrometry for Quantitation of Carbonic Anhydrase 12 in Cultured Renal Carcinoma Cells
|
journal
|
November 2010 |
Affinity Depletion of Plasma and Serum for Mass Spectrometry-Based Proteome Analysis
|
book
|
January 2013 |
Mass Spectrometric Quantitation of Peptides and Proteins Using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA)
|
journal
|
April 2004 |
Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma
|
journal
|
December 2011 |
Critical Steps in the Production of Polyclonal and Monoclonal Antibodies: Evaluation and Recommendations
|
journal
|
January 2005 |
SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device
|
journal
|
May 2009 |
Latest technologies for the enhancement of antibody affinity
|
journal
|
August 2006 |
Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry
|
journal
|
February 2010 |
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|
journal
|
March 2002 |
Phosphopeptide enrichment using metal oxide affinity chromatography
|
journal
|
February 2010 |
Combination of Abundant Protein Depletion and Multi-Lectin Affinity Chromatography (M-LAC) for Plasma Protein Biomarker Discovery
|
journal
|
February 2007 |
Aptamer affinity chromatography:
|
journal
|
August 1999 |
Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis
|
journal
|
August 2005 |
Differences among techniques for high-abundant protein depletion
|
journal
|
August 2005 |
Multi-component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome
|
journal
|
April 2003 |
Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry
|
journal
|
July 2006 |
IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography–mass spectrometry for human plasma proteomics biomarker discovery
|
journal
|
February 2012 |
Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column
|
journal
|
June 2006 |
Effect of Immunoaffinity Depletion of Human Serum during Proteomic Investigations
|
journal
|
October 2005 |
Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma
|
journal
|
August 2005 |
Sepsis Plasma Protein Profiling with Immunodepletion, Three-Dimensional Liquid Chromatography Tandem Mass Spectrometry, and Spectrum Counting
|
journal
|
November 2006 |
Intact-protein-based High-resolution Three-dimensional Quantitative Analysis System for Proteome Profiling of Biological Fluids
|
journal
|
May 2005 |
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
|
journal
|
October 2010 |
Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum
|
journal
|
May 2008 |
A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL Fractionation
|
journal
|
January 2010 |
Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow
|
journal
|
February 2013 |
Optimizing Performance of Glycopeptide Capture for Plasma Proteomics
|
journal
|
March 2010 |
Prediction of high-responding peptides for targeted protein assays by mass spectrometry
|
journal
|
January 2009 |
Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
|
journal
|
January 2011 |
Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisition: Proteomics and 2DE
|
journal
|
July 2014 |
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity
|
journal
|
May 2011 |
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics
|
journal
|
June 2013 |
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
|
journal
|
January 2012 |
In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)
|
journal
|
November 2014 |
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM
|
journal
|
January 2013 |
Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation
|
journal
|
September 2011 |
Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
|
journal
|
October 2007 |
Comparison of protein enrichment strategies for proteome analysis of plasma
|
journal
|
February 2010 |
Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columns
|
journal
|
June 2011 |
Assessment of Two Immunodepletion Methods: Off-Target Effects and Variations in Immunodepletion Efficiency May Confound Plasma Proteomics
|
journal
|
October 2012 |
Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting
|
journal
|
June 2010 |
Quantitative assessment of human serum high-abundance protein depletion
|
journal
|
November 2008 |
Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics
|
journal
|
April 2012 |
iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer
|
journal
|
February 2012 |
Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
|
journal
|
September 2012 |
Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis
|
journal
|
March 2014 |
Alterations in Protein Regulators of Neurodevelopment in the Cerebrospinal Fluid of Infants with Posthemorrhagic Hydrocephalus of Prematurity
|
journal
|
June 2012 |
Proteome Profiling of Human Cerebrospinal Fluid: Exploring the Potential of Capillary Electrophoresis with Surface Modified Capillaries for Analysis of Complex Biological Samples
|
journal
|
April 2008 |
Mouse-Specific Tandem IgY7-SuperMix Immunoaffinity Separations for Improved LC-MS/MS Coverage of the Plasma Proteome
|
journal
|
November 2009 |
Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid
|
journal
|
September 2014 |
Protein Equalizer™ Technology: The quest for a “democratic proteome”
|
journal
|
July 2006 |
Combinatorial Peptide Ligand Libraries as a “Trojan Horse” in Deep Discovery Proteomics
|
journal
|
August 2014 |
Inside human aortic stenosis: A proteomic analysis of plasma
|
journal
|
February 2012 |
Biomarker Discovery for Early Detection of Hepatocellular Carcinoma in Hepatitis C–infected Patients
|
journal
|
December 2013 |
SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors
|
journal
|
December 2012 |
Enrichment strategies in glycomics-based lung cancer biomarker development
|
journal
|
August 2013 |
Improvements in Proteomic Metrics of Low Abundance Proteins through Proteome Equalization Using ProteoMiner Prior to MudPIT
|
journal
|
August 2011 |
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum
|
journal
|
April 2013 |
Mass-Linked Immuno-Selective Assays in Targeted Proteomics
|
journal
|
November 2012 |
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry
|
journal
|
May 2003 |
Modification-specific proteomics: Strategies for characterization of post-translational modifications using enrichment techniques
|
journal
|
October 2009 |
Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications
|
journal
|
December 2013 |
High-Throughput Comparative Proteome Analysis Using a Quantitative Cysteinyl-peptide Enrichment Technology
|
journal
|
September 2004 |
Structure of the IgG-binding regions of streptococcal protein G.
|
journal
|
July 1986 |
Affibody-mediated transferrin depletion for proteomics applications
|
journal
|
November 2007 |
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
|
journal
|
April 2010 |
Lectins: Proteins That Interpret the Sugar Code
|
journal
|
August 2003 |
A Proteomics Platform Combining Depletion, Multi-lectin Affinity Chromatography (M-LAC), and Isoelectric Focusing to Study the Breast Cancer Proteome
|
journal
|
June 2011 |
Development of an improved fractionation of the human plasma proteome by a combination of abundant proteins depletion and multi-lectin affinity chromatography
|
journal
|
October 2014 |
Intracellular antibodies and challenges facing their use as therapeutic agents
|
journal
|
September 2003 |
Intracellular antibodies and cancer: New technologies offer therapeutic opportunities
|
journal
|
June 2010 |
Single-chain antibodies as diagnostic tools and therapeutic agents
|
journal
|
January 2009 |
scFv Antibody: Principles and Clinical Application
|
journal
|
January 2012 |
A human scFv antibody generation pipeline for proteome research
|
journal
|
April 2011 |
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface
|
journal
|
June 1985 |
Selection of human antibody fragments by phage display
|
journal
|
November 2007 |
Use of a Single-Chain Antibody Library for Ovarian Cancer Biomarker Discovery
|
journal
|
July 2010 |
Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies
|
journal
|
June 2010 |
An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers
|
journal
|
October 2009 |
Sequential Multiplexed Analyte Quantification Using Peptide Immunoaffinity Enrichment Coupled to Mass Spectrometry
|
journal
|
December 2011 |
Global Proteomic Assessment of the Classical Protein-Tyrosine Phosphatome and “Redoxome”
|
journal
|
September 2011 |
Temporal Perturbation of Tyrosine Phosphoproteome Dynamics Reveals the System-wide Regulatory Networks
|
journal
|
February 2009 |
Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling
|
journal
|
July 2010 |
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
|
journal
|
July 2009 |
Generation of acetyllysine antibodies and affinity enrichment of acetylated peptides
|
journal
|
September 2010 |
Different techniques for urinary protein analysis of normal and lung cancer patients
|
journal
|
March 2005 |
Different Immunoaffinity Fractionation Strategies to Characterize the Human Plasma Proteome
|
journal
|
June 2006 |
High-abundance protein depletion: Comparison of methods for human plasma biomarker discovery
|
journal
|
January 2010 |
High Dynamic Range Characterization of the Trauma Patient Plasma Proteome
|
journal
|
October 2006 |
Human Plasma N -Glycoproteome Analysis by Immunoaffinity Subtraction, Hydrazide Chemistry, and Mass Spectrometry
|
journal
|
December 2005 |
Two-stage Off-Gel? isoelectric focusing: Protein followed by peptide fractionation and application to proteome analysis of human plasma
|
journal
|
March 2005 |
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
|
journal
|
August 2012 |
Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
|
journal
|
October 2009 |
Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics
|
journal
|
July 2012 |
Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins
|
journal
|
December 2005 |
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
|
journal
|
December 2012 |
Protein Alterations Associated with Pancreatic Cancer and Chronic Pancreatitis Found in Human Plasma using Global Quantitative Proteomics Profiling
|
journal
|
May 2011 |
A Systematic Analysis of Eluted Fraction of Plasma Post Immunoaffinity Depletion: Implications in Biomarker Discovery
|
journal
|
September 2011 |
Mass Spectrometric Immunoassay
|
journal
|
April 1995 |
Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
|
journal
|
June 2009 |
Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead
|
journal
|
May 2011 |
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
|
journal
|
November 2014 |
Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer
|
journal
|
July 2009 |
A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer
|
journal
|
April 2013 |
Serum Soluble CD14 Is a Potential Prognostic Indicator of Recurrence of Human Breast Invasive Ductal Carcinoma with Her2-Enriched Subtype
|
journal
|
September 2013 |
Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens
|
journal
|
February 2014 |
Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer
|
journal
|
May 2014 |
2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer
|
journal
|
December 2008 |
A Highly Sensitive Targeted Mass Spectrometric Assay for Quantification of AGR2 Protein in Human Urine and Serum
|
journal
|
December 2013 |
Sequential depletion of human serum for the search of osteoarthritis biomarkers
|
journal
|
January 2012 |
Identification of a Panel of Novel Serum Osteoarthritis Biomarkers
|
journal
|
November 2011 |
Identification of Potential Prognostic Markers for Knee Osteoarthritis by Serum Proteomic Analysis
|
journal
|
January 2013 |
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease
|
journal
|
June 2011 |
Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies
|
journal
|
January 2015 |
Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease
|
journal
|
January 2014 |
A stable panel comprising 18 urinary proteins in the human healthy population
|
journal
|
April 2012 |
Urine 2DE proteome analysis in healthy condition and kidney disease: Proteomics and 2DE
|
journal
|
August 2014 |
Comparison of different depletion strategies for improving resolution of the human urine proteome
|
journal
|
January 2010 |
Clinical validation of an immunoaffinity LC–MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine
|
journal
|
October 2007 |
A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy
|
journal
|
December 2011 |
Proteomic Identification of Urinary Biomarkers of Diabetic Nephropathy
|
journal
|
February 2007 |
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
|
journal
|
January 2012 |
Recent cerebrospinal fluid biomarker studies of Alzheimer’s disease
|
journal
|
December 2010 |
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
|
journal
|
April 2011 |
Protein Changes in Immunodepleted Cerebrospinal Fluid from a Transgenic Mouse Model of Alexander Disease Detected Using Mass Spectrometry
|
journal
|
January 2013 |
Establishing the Proteome of Normal Human Cerebrospinal Fluid
|
journal
|
June 2010 |
Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome
|
journal
|
February 2011 |
A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome
|
journal
|
April 2015 |
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia
|
journal
|
April 2012 |
Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease
|
journal
|
March 2009 |
Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC–MALDI TOF/TOF
|
journal
|
June 2012 |
Proteomic analysis of human osteoarthritis synovial fluid
|
journal
|
January 2014 |
Microfluidic integration for automated targeted proteomic assays
|
journal
|
April 2012 |
A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine: Human urinary proteome: touching phosphorylation in urine
|
journal
|
February 2010 |